282 related articles for article (PubMed ID: 30519966)
21. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
22. Optimization of hepatitis B cirrhosis detection by stepwise application of transient elastography and routine biomarkers.
Liang XE; Zhong C; Huang L; Yang S; Zhu Y; Chen Y; Hou J
J Gastroenterol Hepatol; 2017 Feb; 32(2):459-465. PubMed ID: 27346683
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
Tan YW; Zhou XB; Ye Y; He C; Ge GH
World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
[TBL] [Abstract][Full Text] [Related]
24. Liver Fibrosis Evaluated With Transient Elastography in 35 Children With Chronic Hepatitis C Virus Infection.
Pokorska-Śpiewak M; Dobrzeniecka A; Lipińska M; Tomasik A; Aniszewska M; Marczyńska M
Pediatr Infect Dis J; 2021 Feb; 40(2):103-108. PubMed ID: 33021594
[TBL] [Abstract][Full Text] [Related]
25. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
[TBL] [Abstract][Full Text] [Related]
26. Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
Huang R; Rao H; Yang M; Gao Y; Wang J; Jin Q; Ma D; Wei L
Dig Dis Sci; 2020 May; 65(5):1491-1500. PubMed ID: 31654313
[TBL] [Abstract][Full Text] [Related]
27. Comparing various cut-offs of aspartate aminotransferase-to-platelet ratio index (APRI) in liver cirrhosis diagnosis among hepatitis C patients in Malaysia.
Mohd Suan MA; Chan HK; Sem XH; Shilton S; Abu Hassan MR
Med J Malaysia; 2021 Nov; 76(6):828-832. PubMed ID: 34806668
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
[TBL] [Abstract][Full Text] [Related]
29. The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients.
Abdel-Hameed EA; Rouster SD; Kottilil S; Sherman KE
Clin Infect Dis; 2021 Aug; 73(3):450-459. PubMed ID: 32459305
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.
Hasson H; Merli M; Galli L; Gallotta G; Carbone A; Messina E; Bagaglio S; Morsica G; Salpietro S; Castagna A; Lazzarin A; Uberti-Foppa C
Liver Int; 2013 Aug; 33(7):1113-20. PubMed ID: 23534616
[TBL] [Abstract][Full Text] [Related]
31. Assessment of native liver fibrosis using ultrasound elastography and serological fibrosis indices in children with biliary atresia after the Kasai procedure.
Hwang J; Yoon HM; Kim KM; Oh SH; Namgoong JM; Kim DY; Cho YA
Acta Radiol; 2021 Aug; 62(8):1088-1096. PubMed ID: 32811156
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.
Chromy D; Schwabl P; Bucsics T; Scheiner B; Strassl R; Mayer F; Aichelburg MC; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T; Mandorfer M
Wien Klin Wochenschr; 2018 Feb; 130(3-4):105-114. PubMed ID: 28744597
[TBL] [Abstract][Full Text] [Related]
33. Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients.
Li Vecchi V; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; La Spada E; Vizzini G; Montalto G; Soresi M
Ann Hepatol; 2013; 12(5):740-8. PubMed ID: 24018492
[TBL] [Abstract][Full Text] [Related]
34. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
[TBL] [Abstract][Full Text] [Related]
35. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus.
Imai H; Kamei H; Onishi Y; Ishizu Y; Ishigami M; Goto H; Ogura Y
Transplant Proc; 2018 Jun; 50(5):1431-1436. PubMed ID: 29705278
[TBL] [Abstract][Full Text] [Related]
37. Liver Fibrosis Assessment in a Cohort of Greek HIV Mono-Infected Patients by Non-Invasive Biomarkers.
Androutsakos T; Schina M; Pouliakis A; Kontos A; Sipsas N; Hatzis G
Curr HIV Res; 2019; 17(3):173-182. PubMed ID: 31549590
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.
Fouad R; Elbaz T; Abdel Alem S; Elsharkawy A; Negm M; Khairy M; Hassany M; Cordie A; El Akel W; Esmat G
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):882-887. PubMed ID: 29727382
[TBL] [Abstract][Full Text] [Related]
39. Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.
Valcour VG; Rubin LH; Obasi MU; Maki PM; Peters MG; Levin S; Crystal HA; Young MA; Mack WJ; Cohen MH; Pierce CB; Adimora AA; Tien PC;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):266-73. PubMed ID: 26885801
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
Charpentier C; Champenois K; Gervais A; Landman R; Joly V; Le Gac S; Larrouy L; Damond F; Brun-Vézinet F; Descamps D; Yazdanpanah Y
PLoS One; 2013; 8(3):e59205. PubMed ID: 23527135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
